# Safety and Pharmacodynamic Study of CD-NP

> **NCT00482937** · PHASE1 · COMPLETED · sponsor: **Nile Therapeutics** · enrollment: 22 (actual)

## Conditions studied

- Heart Failure, Congestive

## Interventions

- **DRUG:** CD-NP

## Key facts

- **NCT ID:** NCT00482937
- **Lead sponsor:** Nile Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2007-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00482937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00482937, "Safety and Pharmacodynamic Study of CD-NP". Retrieved via MORVS 2026-10-15 from https://api.morvs.ai/clinical/NCT00482937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*